STMicroelectronics N.V. Form 6-K Summary
Business Context and Reporting Period
This filing covers the unaudited interim results for the three months ended March 29, 2014 (First Quarter 2014). STMicroelectronics N.V. is a global independent semiconductor company designing, developing, and manufacturing integrated circuits and discrete devices. The company operates primarily through two reportable segments: Sense & Power and Automotive Products (SP&A) and Embedded Processing Solutions (EPS).
Key Financial Metrics
| Metric | Q1 2014 | Q1 2013 | Q4 2013 |
|---|---|---|---|
| Net Revenues | $1,825 million | $2,009 million | $2,015 million |
| Gross Profit | $599 million | $628 million | $662 million |
| Gross Margin | 32.8% | 31.3% | 32.9% |
| Operating Loss | $(4) million | $(281) million | $(11) million |
| Net Loss (Parent) | $(24) million | $(171) million | $(36) million |
| Diluted EPS | $(0.03) | $(0.19) | $(0.04) |
| Net Cash from Operating Activities | $53 million | $66 million | N/A |
| Free Cash Flow (Non-GAAP) | $(51) million | $(65) million | N/A |
| Net Financial Position (Non-GAAP) | $612 million | $1,013 million | $741 million |
| Total Financial Debt | $1,133 million | $897 million | $1,153 million |
Material Changes vs. Prior Periods
- Revenue Decline: Net revenues decreased 9.2% year-over-year (YoY) and 9.4% sequentially. The decline was driven by a 6% decrease in average selling prices and a 3% volume decrease, largely due to the phase-out of legacy ST-Ericsson products. Excluding legacy ST-Ericsson products, revenues increased 0.7% YoY.
- Segment Performance: The SP&A segment grew 6% YoY, driven by Automotive and Industrial & Power Discrete. The EPS segment declined 28% YoY due to the ST-Ericsson wind-down and weak Digital Convergence Group performance, partially offset by growth in microcontrollers.
- Profitability Improvement: Operating loss narrowed significantly to $4 million from $281 million in Q1 2013. This improvement was driven by a 25% reduction in combined SG&A and R&D expenses (due to ST-Ericsson exit and cost initiatives) and a sharp decrease in impairment/restructuring charges ($12 million vs. $101 million in Q1 2013).
- Liquidity: Net cash decreased by $92 million during the quarter. The Net Financial Position improved to a net cash position of $612 million, down from $741 million at year-end 2013, reflecting negative free cash flow and dividend payments.
Guidance, Outlook, and Risks
- Q2 2014 Outlook: Management expects revenues to increase sequentially by approximately 2% at the mid-point. Gross margin is expected to be 33.6% (+/- 2.0 percentage points). Legacy ST-Ericsson revenues are expected to be less than half of the $63 million recorded in Q1.
- Capital Investment: Full-year 2014 capital expenditure is anticipated to be between $510 million and $550 million, focused on 20-nm process evolution, capacity growth, and cost savings.
- Dividends: The company proposed cash dividends of $0.10 per share for Q2 and Q3 2014.
- Risks and Contingencies:
- ST-Ericsson Wind-down: The joint venture entered liquidation in April 2014. STMicroelectronics' exposure is limited to covering 50% of wind-down needs, estimated not to exceed $30 million.
- 3Sun Investment: The company may need to provide additional financial resources to its 33.3% stake in 3Sun (photovoltaic panels), with potential exposure up to 50% of required funding if a partner withdraws.
- Legal Proceedings: Ongoing litigation with Tessera regarding patent infringement; trial scheduled for November 2014. Estimated potential losses for known claims range from $10 million to $30 million.
- FX Exposure: Results are sensitive to USD/Euro fluctuations. The effective average exchange rate was $1.35/€1.00 in Q1 2014.
Key Facts for Investor Verification
- Verify the trajectory of the ST-Ericsson wind-down and the accuracy of the $30 million exposure estimate.
- Monitor the execution of the "Plan 600" cost reduction initiative to ensure operating expenses remain in the $600-$650 million quarterly range.
- Assess the recovery of the Digital Convergence Group (DCG) within the EPS segment, which remains a drag on profitability.
- Review the status of the Nano2017 R&D funding program approval by the European Union, expected in Q2 2014.
- Track the outcome of the Tessera patent litigation scheduled for trial in late 2014.